REVELATION PHARMA, LLC – Trademark Portfolio
Entity Type: 16
REVELATION PHARMA, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include CONSULTRX. The owner is based in ENGLEWOOD, CO.
9777 PYRAMID COURT
SUITE 230
ENGLEWOOD, CO 80112
Showing of trademarks Trademarks
Trademark Classifications
REVELATION PHARMA, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does REVELATION PHARMA, LLC have?
REVELATION PHARMA, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does REVELATION PHARMA, LLC file in?
REVELATION PHARMA, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are REVELATION PHARMA, LLC's most well-known trademarks?
REVELATION PHARMA, LLC's registered trademark portfolio includes well-known marks such as CONSULTRX. These are among 1 currently registered trademark in the portfolio.
What is REVELATION PHARMA, LLC's trademark registration success rate?
REVELATION PHARMA, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.